Eulji University   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Seongnam City Korea, Republic of (1967)

Organization Overview

First Clinical Trial
2005
NCT00325637
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Department of Family medicine, Eulji University Hospital | Department of Urology, Eulji University, College of Medicine | Eulji Central Hospital | Eulji General Hospital | Eulji University Hospital | Nowon Eulji University Hospital | Seoul Eulji Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Juvenile (Phase 3)

Arthritis, Psoriatic (Phase 3)

Arthritis, Rheumatoid (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Foot (Phase 3)

Diphtheria (Phase 3)

Essential Hypertension (Phase 3)

Fasciitis (Phase 4)

Fasciitis, Plantar (Phase 4)

Foot Ulcer (Phase 3)

Glomerulonephritis (Phase 3)

Hepatitis (Phase 3)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 3)

Hepatitis C (Phase 4)

Hyperlipidemias (Phase 4)

Hyperlipoproteinemias (Phase 4)

Hyperplasia (Phase 3)

Hypertension (Phase 3)

Influenza, Human (Phase 3)

Joint Diseases (Phase 3)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Osteoporosis (Phase 4)

Poliomyelitis (Phase 3)

Prostatic Hyperplasia (Phase 3)

Prostatic Neoplasms (Phase 4)

Renal Insufficiency (Phase 4)

Spondylitis (Phase 3)

Spondylitis, Ankylosing (Phase 3)

Stroke (Phase 3)

Tetanus (Phase 3)

Ulcer (Phase 3)

Ureteral Calculi (Phase 4)

Ureterolithiasis (Phase 4)

Whooping Cough (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 26
  • # of Trial APIs: 34